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Previous studies have shown twohomologous chromodomain
modules in the HP1 and Polycomb proteins exhibit discrimina-
tory binding to related methyllysine residues (embedded in
ARKS motifs) of the histone H3 tail. Methylated ARK(S/T)
motifs have recently been identified in other chromatin factors
(e.g. linker histone H1.4 and lysine methyltransferase G9a).
These are thought to function as peripheral docking sites for the
HP1 chromodomain. In vertebrates, HP1-like chromodomains
are also present in the chromodomain Y chromosome (CDY)
family of proteins adjacent to a putative catalytic motif. The
human genome encodes three CDY family proteins, CDY,
CDYL, and CDYL2. These have putative functions ranging from
establishment of histone H4 acetylation during spermiogenesis
to regulation of transcription co-repressor complexes. To delin-
eate the biochemical functions of the CDY family chromodo-
mains, we analyzed their specificity ofmethyllysine recognition.
We detected substantial differences among these factors. The
CDY chromodomain exhibits discriminatory binding to lysine-
methylated ARK(S/T) motifs, whereas the CDYL2 chromodo-
main binds with comparable strength to multiple ARK(S/T)
motifs. Interestingly, subtle amino acid changes in the CDYL
chromodomain prohibit such binding interactions in vitro and
in vivo. However, point mutations can rescue binding. In sup-
port of the in vitro binding properties of the chromodomains,
the full-length CDY family proteins exhibit substantial variabil-
ity in chromatin localization. Our studies underscore the signif-
icance of subtle sequence differences in a conserved signaling
module for diverse epigenetic regulatory pathways.
The human Y chromosome has been thoroughly sequenced
and compared with partially sequenced Y chromosomes of
chimpanzee and mouse (1–3). The Y chromosomes are
believed to be enriched in genes essential for spermatogenesis
and testis development. Interstitial Y chromosome deletions
are associated with spermatogenic failure and male infertility
(1, 4, 5). One gene that is present in multiple copies on the
human Y chromosome is CDY,5 which exhibits testis-specific
expression (1). Interestingly, the mouse Y chromosome does
not encode CDY, suggesting a developmentally advanced usage
of CDY in primates (3).
The human CDY gene seems to be derived from the autoso-
mal homologs CDYL or CDYL2 (Fig. 1, A and B) (6). CDYL is
ubiquitously expressed, whereas CDYL2 exhibits selective
expression in tissues of testis, prostate, spleen, and leukocytes
(6). Themouse genome also encodes related CDYL andCDYL2
genes (Fig. 1B). The presence of CDY-like genes appears to be a
hallmark of echinoderm and vertebrate genomes. In sea urchin
and chicken genomes we found only one CDY-like gene that
corresponds to mammalian CDYL2 (Fig. 1B).
CDY family proteins have two conserved domains implicated
in histone modification and recognition; that is, a chromodo-
main followed by an enoyl-coenzyme A hydratase/isomerase
(ECH) putative catalytic domain (Fig. 1A). Previously, it was
shown that the chromodomain of human CDY interacts with
methylated lysine 9 of the histone H3 tail (H3K9me) (7). The
ECH domain has been implicated in conflicting chromatin
modification processes. One function of this domain is acetyla-
tion of germ line histone H4 (8). Another function is direct
recruitment of histone deacetylases to sites within somatic cells
(9).
Epigenetic control of gene expression hinges on effecter rec-
ognitionmodules that help establish appropriate methyllysine-
dependent interactionswith chromatin (for review, see Ref. 10).
The HP1 and Polycomb chromodomains (Fig. 1B), which are
similar to the chromodomains of CDY family proteins, distin-
guish twomethylated lysine residues withinARKSmotifs in the
H3 tail (H3K9me and H3K27me) (11–16). Sequences immedi-
ately preceding the ARK(S/T)motif impact on the specificity of
chromodomain interactions. HP1 chromodomains are subject
to a binary methyl-phos switch as they are prohibited from
interaction with H3K9me3 upon phosphorylation of the adja-
cent serine 10 in the H3 tail (H3S10ph) (17–20).
Additional complexity in epigenetic control arises from
usage of histone variants. For example, substitutions of histone
H3with variants results in indexing of chromatin for transcrip-
tional activation or repression (22, 23), and an H3 barcode
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hypothesis has been proposed (24). In human testis, three
somatic histoneH3 variants (H3.1,H3.2, andH3.3) are encoded
together with a testis-specific subtype (H3t) (25). These vari-
ants have no amino acid changes N-terminal to the ARKS
motifs, except in theH3t subtype. Althoughmass spectrometry
has identified in vivo methylation of H3tK27 (26), an effector
binding module has not yet been reported. Another lysine-
methylated ARKS motif is found in the N-terminal tail of a
linker histone H1 subtype in humans (H1.4K26) (27, 28).
An ARKT mimic of H3K9me has also been identified in the
lysine methyltransferase G9a (G9aKme), suggesting a broader
usage of ARK(S/T) motifs in human epigenetic signaling (29,
30). The G9aKme is targeted by the HP1 chromodomain in one
transcriptional co-repressor complex (30). Interestingly, the
human CDYL protein was also found associated with G9aKme
in pulldown experiments from cellular extracts.
Because methylation of lysine residues within numerous
ARK(S/T) motifs appears to orchestrate complex epigenetic
pathways (for review, see Refs. 29, 32–34), determining the
specificity of effectors may be a paradigm for understanding
epigenetic signaling. Using a series of in vitro and cell-based
assays, we studied the biochemical specificity of the chromodo-
mains in the CDY family proteins. Our studies reveal a surpris-
ing variability in discriminatory interactions of CDY and
CDYL2 chromodomains with methylated ARK(S/T) motifs.
EXPERIMENTAL PROCEDURES
Antibodies—Polyclonal antibodies specific for H3K9me3
were a gift from Dr. Thomas Jenuwein (IMP Vienna). The
monoclonal antibody against mouse HP1 was obtained from
Chemicon, and the monoclonal anti-FLAG antibody was pur-
chased from Sigma.
Peptide Preparation—The sequences of the synthetic pep-
tides corresponding to histone tails are listed below. A non-
native tyrosine residue at the C terminus of each peptide was
used for concentration determination by UV absorption meas-
urements. Peptides were labeled with fluorescein as previously
described (13):
H3K9me1, H3K9me2, H3K9me3: NH2-ARTKQTARK-














Molecular Biology—For binding studies, the chromodo-
mains of human CDY (GenBankTM AF000981; residues 1–78),
human CDYL (GenBankTM AF081259; residues 1–133,
58–133, or 60–133), mouse CDYL (GenBankTM AF081261;
residues 1–128 or 51–128), and mouse CDYL2 (GenBankTM
AK015452; residues 1–75) were amplified by PCR and cloned
into the BamHI/NdeI sites of the pET16b vector (Novagen).
Full-length CDY and CDYL2 were cloned into a modified pMAL
vector (NewEnglandBiolabs) for expression asMBP-His fusion
proteins (details are available upon request). To generate C-ter-
minal epitope-tagged constructs for the transient expression of
full-length humanCDYandhumanCDYL,we used PCR ampli-
ficationwith reverse primers containing the sequence encoding
for the FLAG and hemagglutinin peptides (for details, see Ref.
47). cDNAs were cut with the appropriate restriction enzymes
and cloned into the BamHI/XbaI sites of the pcDNA3.1 vec-
tor (Invitrogen). Site-directed mutagenesis was performed
according to the QuikChange protocol (Stratagene).
Fluorescence Polarization Binding Assays—Fusion proteins
with the N-terminal His tag were expressed in Escherichia coli
strain BL21(DE3) (Novagen) and purified by Ni2-affinity
chromatography (Qiagen) and gel filtration chromatography
(Superdex 75 resin, GE Healthcare). N-terminal MBP-His
fusion proteins of full-length CDY and CDYL2 were expressed
in BL21 RIL (Novagen) and purified consecutively on maltose
and nickel-nitrilotriacetic acid resins. Protein concentrations
were determined by absorbance spectroscopy using predicted
extinction coefficients (for CDY chromodomain 280 19,750
M1cm1; for MBP-His-CDY 280  113,000 M1cm1; for
CDYL chromodomain 280  15,220 M1cm1; for CDYL2
chromodomain 280 20,910 M1cm1; for MBP-His-CDYL2
280 126,000 M1cm1). Peptide concentrations were deter-
mined using absorbance spectroscopy (extinction coefficient
for tyrosine, 280  1280 M1cm1; extinction coefficient for
fluoresceinated peptides 492  68,000 M1cm1). Fluores-
cence polarization binding assays were performed under con-
ditions of 20 mM imidazole, pH 8.0, 25 mM NaCl, 2 mM dithio-
threitol and in the presence of 100 nM fluorescein-labeled
peptide following a previously described protocol (13). Data
were obtained using a Teacan Polarion 96-well plate reader or a
Hidex Chameleon II plate reader (100 flashes). Sample plates
were kept on ice until fluorescence reading at room tempera-
ture. Titration binding curves were analyzed using Kaleida-
Graph (Synergy Software) as previously described (13).
Isothermal Titration Calorimetry—Isothermal titration cal-
orimetry (ITC) experiments were carried out as described pre-
viously using a VP-ITC instrument (MicroCal) (13). Chromo-
domains of CDY or HP1 were dialyzed against 50 mM sodium
phosphate, pH 8.0, 25 mM NaCl, and 2 mM dithiothreitol. Pep-
tides were purified by gel filtration in water (G10 resin, GE
Healthcare), lyophilized, and dissolved in the chromodomain
dialysis buffer. Exothermic heats of reaction (cal/s) were
measured at the indicated temperatures by automated
sequencing of 30 injections of the H3 peptides (750 M), each
10l, spaced at 2-min intervals, into 1.41ml of chromodomain
(CDY at 60M;HP1 at 70M). Binding curveswere analyzed by
non-linear least squares fitting of the data using the Origin
(MicroCal) software package.
Cell Transfection—NIH3T3 (American Cell Culture Collec-
tion) and mouse embryonic fibroblast (a kind gift of Dr.
Thomas Jenuwein, IMP Vienna) cells were grown at 37 °C in a
humidified atmosphere, 5% CO2 using Dulbecco’s modified
Eagle’s medium (Invitrogen) supplemented with 10% fetal
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bovine serum, 2 mM glutamine. Cells were transfected using
Lipofectamine 2000 as instructed by the manufacturer
(Invitrogen).
Immunofluorescence—For immunofluorescence staining,
cells were grown and transfected on glass coverslips. 48 h post-
transfection, cells were fixed in solution I (1 PBS, 3.7% form-
aldehyde, 1% Triton X-100, 2% Nonidet P-40) for 10 min and
then washed in 1 PBST (PBS, 1% Triton X-100) for 3  10
min. Slides were blocked for 1 h (1 PBST, 5% goat serum, 2%
bovine serum albumin) and incubated with the indicated pri-
mary antibodies overnight in a humidified atmosphere. Dilu-
tions for primary antibodieswere anti-H3K9me3 (1:1500), anti-
HP1 (1:2000), and anti-FLAG (1:500). Slides were washed in
1PBST for 3  10 min and incubated with the appropriate
secondary antibodies (Molecular Probes, Jackson ImmunoRe-
search) for 2 h in a humidified atmosphere. After washing in 1
PBST, DNA was stained with DAPI (1 g/ml) for 10 s. Pictures
were taken on a Leica SP5 confocal microscope or a Zeiss Axio-
pod II both equipped with 60 lenses.
RESULTS
Variability in Binding to H3Methylated on Lys-9—The CDY
class of chromodomains exhibits high homology to HP1 and
Polycomb chromodomains (Fig. 1B). Three aromatic residues
were shown to be necessary for assembling amethyllysine bind-
ing aromatic cage in HP1 and Polycomb chromodomains (11,
12, 16). Interestingly, the chromodomains of the CDYL pro-
teins do not have the first aromatic cage residue, suggesting
substantial difference in the function of this factor. A three-
dimensional structure corresponding to the chromodomain of
CDYL2 has been deposited in the protein data bank (PDB
accession code 2dnt). We prepared a superposition of the
CDYL2 structure with the peptide-bound structure of the HP1
chromodomain involving an H3K9me3 peptide (11) (Fig. 1C).
This comparison established that CDYL2 and, by homology,
CDY and CDYL chromodomains, despite amoderate sequence
identity (42%), have tertiary structures similar to HP1.
Whereas HP1 and Polycomb chromodomains are 50-residue
modules, the CDY family chromodomains are 55-residuemod-
FIGURE 1. The CDY protein family and their chromodomains. A, schematic representation of the primary structures of CDYL, CDYL2, and CDY. a.a., amino
acids. B, sequence alignment of CDY family chromodomains, which are related toHP1 andPolycomb chromodomains. Three stars above the sequencemark the
positions of the aromatic cage residues. Secondary structure elements above the sequence correspond to that deduced for CDYL2 (from PDB code 2dnt). The
accession codes are: humanCDY, Q9Y6F8;Macaque CDY, AJ31484;, humanCDYL, Q9Y232;mouse CDYL, Q9WTK2; humanCDYL2, AK096185;Macaque CDYL2,
AY271718;mouse CDYL2, AK015452; chicken CDYL2, XP_418964; sea urchin CDYL2, XP 781347. C, backbone superposition of the three-dimensional structure
of the human CDYL2 chromodomain (green, from PDB code 2dnt) on the structure of the Drosophila HP1 (from PDB code 1kne) chromodomain (pink) bound
to an H3K9me3 peptide (black). D, interaction of recombinant human CDY family chromodomains with an H3K9me3 peptide as measured by fluorescence
polarization. Averages from at least three independent measurements are plotted. See Table 1 for dissociation constants.
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ules containing a longer C-terminal -helix (Fig. 1B). Previ-
ously, binding of the CDY chromodomain to H3K9me2 and
H3K9me3 peptides was identified through protein microarray
analysis (7).
To determine the specificity and affinity for methylated his-
tone lysine residues among the three CDY family members,
recombinant chromodomains of CDY, CDYL, and CDYL2
were expressed in bacteria and purified. Because the CDYL
chromodomain has an incomplete aromatic cage plus anN-ter-
minal extension (Fig. 1, A and B), we prepared a recombinant
construct that included the N terminus of the protein together
with the chromodomain module. Recombinant proteins were
used in fluorescence polarization assays to measure equilib-
riumbinding to fluoresceinated synthetic peptides correspond-
ing to the histone H3 tail. The binding data are shown in Fig.
1D, and the dissociation constants are listed in Table 1. In
accordance with sequence prediction and the presence of an
incomplete aromatic cage, we measured no binding of the
CDYL chromodomain to H3K9me3 (KD  500 M). Surpris-
ingly, we measured a substantial difference in the dissociation
constants associated with CDY and CDYL2. The interaction of
the CDY chromodomain with the H3K9me3 peptide is 8-fold
stronger than that of CDYL2. The results confirm subtle
sequence differences among CDY family chromodomains,
impacting on their interaction with methylated histone tails.
The binding studies potentially implicate each CDY family
member as part of distinct chromatin modification pathways.
To compare the binding affinity of the chromodomain con-
structs with that of the full-length proteins, we prepared
recombinant full-length CDY and CDYL2 (Fig. 2) and meas-
ured binding to the H3K9me3 peptide by fluorescence polar-
ization (Fig. 2). As observed for the chromodomain fragments,
the full-length CDY protein displayed a significantly stronger
binding (by 10-fold) compared with the full-length CDYL2
protein. These results reveal the chromodomain of CDY and
CDYL2 are able to bind to methylated ARK(S/T) motifs
autonomously.
Distinct in Vivo Distribution of CDY, CDYL, and CDYL2
Proteins—Given theCDYLchromodomain does not bind to the
H3K9me3 peptide and the CDY chromodomain binds more
avidly than the CDYL2 chromodomain, we investigated the in
vivo localization of these proteins in relation to heterochroma-
tin in mammalian systems. We
made use of mouse fibroblast cells
(NIH3T3 and MEF cells) that show
a distinct pattern of DNA-dense,
pericentromeric heterochromatin
regions in the nucleus. These coin-
cide with local enrichment of
H3K9me3 modification. The distri-
bution of CDY family proteins in
these cells was compared using
transiently expressed fusion con-
structs that encode their full-length
polypeptides with a C-terminal
FLAG tag. As Fig. 3 shows, all three
fusion proteins displayed an exclu-
sively nuclear distribution (see also
supplemental Fig. S1).
In all cells inspected, we detected
the transiently expressed CDY pro-
tein excluded from the nucleoli and
enriched at the many large DAPI-
dense regions reminiscent of the
endogenous HP1 protein (17)
(supplemental Fig. S2). Previously,
Kim et al. (7) also showed CDY and
FIGURE 2. Interaction with methylated lysine residues is an intrinsic property of CDY family proteins.
A, interaction of recombinant full-length human CDY and mouse CDYL2 proteins fused to MBP with an
H3K9me3 or the corresponding unmodified peptide asmeasured by fluorescence polarization. Averages from
at least three independentmeasurements are plotted. B, recombinantMBP fusion proteins used for themeas-
urements in panel A were run on SDS-PAGE gels and stained with Coomassie Blue. Arrows indicate the MBP-
CDY and MBP-CDYL2 recombinant proteins. Major degradation products co-purifying with the recombinant
proteins are indicated. Molecular weight (MW) markers are shown on the left.
TABLE 1
Dissociation constants (M) measured by fluorescence polarization
for CDY family chromodomains interacting with synthetic peptides
as described under “Experimental Procedures”
Peptide CDY CDYL CDYL2
H3 Lys-9
Unmodified 300 500 500
H3K4me3 300 500 500
H3K9ac 300 500 500
H3K9me1 3.4 0.5 500 67 10
H3K9me2 0.7 0.1 500 8.9 1.1
H3K9me3 0.5 0.1 452 81 3.9 0.5
H3K4me2K9me2 0.9 0.2 500 11.0 2.1
H3K9me3S10ph 38 4 500 500
H3 Lys-27
Unmodified 500 500 500
H3K27ac 500 500 500
H3K27me1 300 113 15
H3K27me2 119 37 18.4 3.1
H3K27me3 76 11 500 12.4 1.2
H3K27me3S28ph 500 500
Testis H3 Lys-27
H3tK27me3 7.5 0.8 500 2.6 0.4
H1.4 Lys-26
Unmodified 500 500 500
H1.4K26me3 10 1 500 2.2 0.4
G9a Lys-185
Unmodified 185 17 500 500
G9a-K185me1 36 9 500 108 27
G9a-K185me3 0.6 0.2 500 4.9 1.2
Methyllysine Recognition by CDY Family of Chromodomains
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HP1 exhibit overlapping distributions in chromatin with the
H3K9me3 modification. Although the transiently expressed
CDYL protein was also excluded from the nucleoli, CDYL
showed a diffuse distribution pattern that never overlapped
with regions of H3K9me3 (Figs. 3B and supplemental Fig. S2B).
Interestingly, the CDYL2 protein was found throughout the
nucleus in a punctate distribution pattern with pronounced
cell-to-cell variation. Whereas some nuclei displayed granular
staining of CDYL2, others showed larger areas of CDYL2
enrichment (Figs. 3C and supplemental Fig. S3C). Although
CDYL2 enrichment at DAPI dense regions was less pro-
nounced as compared with CDY, all cells analyzed exhibited
someCDYL2 co-localizedwith regions of H3K9me3. Together,
these observations underscore substantial differences in chro-
matin recognition and binding of the CDY family proteins.
CDY and CDYL2 Are Differentially Sensitive to the Degree of
Lysine Methylation—The level of methylation (mono-, di-, or
trimethylation) of lysine residues in histone tails is important
for chromatin regulation (10, 35). We, therefore, measured the
binding affinities of CDY andCDYL2 as a function of themeth-
ylation level on H3K9. Previous studies as well as data listed in
Table 2 indicate that theHP1 chromodomain exhibits 2–3-fold
reduced interaction with H3K9me2 peptide as compared with
H3K9me3 peptide, whereas the binding toH3K9me1 peptide is
substantially weaker. We found CDYL2 to resemble these fea-
tures in HP1 (Table 1). However, the CDY chromodomain
showed 20-fold stronger binding to H3K9me1 as compared
with CDYL2. Interestingly, the binding of CDY to the
H3K9me1 peptide is as efficient as the binding of CDYL2 or
HP1 to the H3K9me3 peptide (Tables 1 and 2).
To determine the thermody-
namic basis for the unusually strong
binding of CDY to the methylated
H3 tail, we performed isothermal
titration calorimetry. We studied
the chromodomains of CDY and
Drosophila HP1 proteins under
identical solution conditions (Table
2). These measurements showed
CDY binds the H3K9me3 peptide
8-fold stronger than HP1. The free
energy of binding to the H3 tail is
more favorable for CDY by 1.2 kcal/
mol. Isothermal titration calorime-
try measurements of CDY binding
to the H3K9me3 peptide at five dif-
ferent temperatures allowed us to
estimate the heat capacity of bind-
ing (	Cp0.22 kcal/molK). The
small 	Cp suggests negligible con-
formational changes occur in the
CDY chromodomain upon binding
to theH3 tail, a result in close agree-
mentwith that found forDrosophila
HP1 (11, 36).
Using calorimetry, we found
the enthalpy of binding to the
H3K9me3 peptide is substantially
more favorable for CDY than for
HP1. This finding emphasizes the
FIGURE 3. Differential nuclear distribution of CDY family proteins. FLAG-tagged human CDY (A), human
CDYL (B), or mouse CDYL2 (C) were transiently expressed in NIH3T3 cells. Immunostaining with anti-FLAG-
specific antibodies (green) and anti-H3K9me3 (red)-specific antibodies was analyzed by confocal microscopy.
The merged image corresponds to the overlay of the two color channels. Yellow areas indicate colocalization
sites for CDY family proteins with H3K9me3modification. Cells of medium expression level representative for
the nuclear distribution of the CDY family proteins are shown (see supplemental Fig. S1 formore images). DNA
inside the cell nucleus was stained with DAPI and defines areas of high DNA density that are presumed to be
heterochromatic. Scale bar, 10 m.
TABLE 2
Thermodynamic parameters for binding to H3 peptides methylated on Lys-9
Isothermal titration calorimetry analysis of the human CDY chromodomain is compared with the Drosophila HP1 chromodomain under identical solution conditions.
Protein Peptide T KD H N G TS
° C M kcal/mol kcal/mol kcal/mol
CDY H3K9me3 5 0.11 0.03 11.83 0.04 0.97 8.61 3.22
CDY H3K9me3 10 0.14 0.05 12.62 0.03 0.96 8.54 4.08
CDY H3K9me3 15 0.30 0.07 13.69 0.03 1.00 8.59 5.10
CDY H3K9me3 20 0.35 0.11 14.99 0.04 0.99 8.57 6.42
CDY H3K9me3 25 0.73 0.17 16.19 0.04 1.02 8.53 7.66
CDY H3K9me2 15 0.86 0.16 17.21 0.04 1.03 8.23 8.98
CDY H3K9me1 15 7.86 1.1 17.70 0.04 1.18 6.38 11.32
HP1 H3K9me3 16 2.3 0.1 9.71 0.04 1.02 7.36 2.46
HP1 H3K9me2 16 6.9 0.2 9.47 0.04 1.02 6.78 2.69
HP1 H3K9me1 16 31.3 0.5 7.75 0.03 1.04 5.92 1.81
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ability of CDY to establish more favorable polar interactions
with the H3 tail than those used by HP1. Previous studies have
shown that recognition of methyllysine by the HP1 chromodo-
main is driven by cation- interactions between themethylated
ammonium group of methylated H3K9 and the side chains of
three aromatic residues (11, 16). Themagnitude of the cation-
interaction depends on the electron density of the aromatic
ring, which can substantially vary from a tyrosine to a pheny-
lalanine as well as the degree of solvent exposure in the inter-
action site (37, 38).Whereas both CDYL2 andHP1 have a tyro-
sine at the first position of the aromatic cage, this position in
CDY is substitutedwith a phenylalanine residue (Fig. 1B). Inter-
estingly, this phenylalanine residue in CDY is further posi-
tioned between two polar (glutamic acid) residues that appear
to improve solvent exposure of the aromatic cage. Together,
these observations suggest that subtle amino acid changes sur-
rounding the aromatic cage can lead to substantial differences
in the strength of the cation- interactions between chromo-
domains and methylated lysine residues.
CDY and CDYL2 Respond to a Binary Switch—A binary
switch mechanism has been associated with the simultaneous
presence of the H3K9me3 and H3S10ph modifications on the
same histone tail (H3K9me3S10ph) (19, 20). Human HP1 vari-
ants are unable to interact with chromatin during mitosis
because of the overwhelming presence of serine 10 phosphoryl-
ation (17, 18). In addition to its relevance tomitosis, H3S10ph is
associated with transcriptionally active chromatin (10). To
investigate the response of CDY and CDYL2 to such a binary
switch, we performed additional fluorescence polarization
binding assays. We found that both CDY and CDYL2 chromo-
domains are sensitive to the presence of H3S10ph. The binding
to the H3K9me3S10ph peptide is 76-fold weaker for CDY and
100-fold weaker for CDYL2 as compared with binding to the
H3K9me3 peptide (Table 1).
CDY and CDYL2 Chromodomains Bind to a Similar Frag-
ment of the H3 Tail—The comparison of the structure of the
CDYL2 chromodomain with that of HP1 suggests that H3 tail
residues 5 through 10 should be suf-
ficient for binding to CDY and
CDYL2 chromodomains (11) (Fig.
1C). The interaction of CDY and
CDYL2 chromodomains with the
H3 tail involves one residue C-ter-
minal to themethyllysine, serine 10.
As discussed above, serine 10 phos-
phorylation has a major impact on
binding affinity. To determine to
what extent residues N-terminal to
the methyllysine could impact on
CDY and CDYL2 interaction with
the H3 tail, we tested the influence
of an adjacent modification on
binding affinity, the presence of
methylation at H3K4. We per-
formed additional fluorescence
binding assays using a peptide with
simultaneous dimethylations at
H3K4 and H3K9 (H3K4me2K9me2
peptide). As listed in Table 1, binding of CDY andCDYL2 chro-
modomains to the H3K4me2K9me2 peptide is nearly the same
as interaction with H3K9me2, 1.2-fold weaker. This finding
suggests residue 4 of the H3 tail (position n-5) does not impact
on the binding of CDY and CDYL2 to the H3 tail, similar to
what has been observed for the interaction of Drosophila HP1
with the H3 tail (11).
PointMutations Rescue CDYL Binding to the H3 Tail—Table
2 shows that we could not measure appreciable binding of the
CDYL chromodomain to any methylated H3K9 peptide or the
unmethylated peptide. We speculated that the critical contrib-
uting factor might be the absence of one of the residues in the
aromatic cage (Fig. 1B). Given the 70% sequence identity
between CDYL and CDY, we asked whether the H3 tail could
bind to CDYL using alternate histone H3 modifications. We
concentrated on methylated H3K4 (H3K4me3) and acetylated
H3K9 (H3K9ac)modifications, as bothmodifications are found
associated with the histone H3.3 variant within transcription-
ally active chromatin. As shown in Table 1, we found no appre-
ciable binding of CDYL to either of these peptides. We then
asked whether the N-terminal extension of the chromodomain
in CDYL could interfere with binding interactions. By prepar-
ing a separate recombinant construct of human CDYL that
excluded the N-terminal extension, we measured the affinity
for methylated and unmethylated H3 peptides again and
observed no substantial differences (data not shown). The cor-
responding recombinant chromodomain of the mouse CDYL
also did not bind to the H3K9me3 peptide (data not shown).
We then asked whether we could establish efficient binding
of the CDYL chromodomain to the H3K9me3 peptide by using
site-directed mutagenesis. We used the CDY sequence as a
guide to prepare point mutations in CDYL. To restore the aro-
matic cage, we prepared a Leu-61 to Phe mutant (position 4 in
the chromodomain; Figs. 1B and 4A). Thismutant exhibits neg-
ligible improvement in binding affinity for the H3K9me3 pep-
tide (Fig. 4B and Table 3). In the structure of the complex of
HP1with theH3 tail, the side chain of the residue preceding the
FIGURE 4. Point mutations rescue CDYL H3K9me3 binding. A, close-up view of the aromatic cage and
surrounding secondary structure elements of the HP1 chromodomain interacting with H3K9me3 (PDB code
1kne). The side chains of E3 and E38 form hydrogen bonds with the backbone of the H3 tail and are solvent-
exposed. Residues are numbered according to the sequence alignment in Fig. 1B. B, fluorescence polarization
analysis of wild-type (WT) and mutant human CDYL chromodomains interacting with an H3K9me3 peptide.
Averages from at least three independent measurements are plotted.
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first aromatic residue is a Glu (position 3 in the chromodo-
main), which forms intermolecular hydrogen bond with the
backbone of Lys 9 (Fig. 4A). Glu-3 also improves solvent expo-
sure at the binding pocket of the HP1 chromodomain. Because
this residue is substituted with an Ala in human CDYL, we
tested the effect of an Ala to Glu mutation for binding to
the H3K9me3 peptide and measured a small but noticeable
improvement in binding (factor of 3) (Fig. 4B). Subsequently,
we prepared a double mutant of CDYL with substitutions at
both positions 3 and 4 of the chromodomain and found a
synergistic effect (30-fold improvement in binding) (Fig. 4B,
Table 3).
Because themutation of the CDYL chromodomain residue 3
exhibited a synergistic effect with the addition of the aromatic
residue 4, we hypothesized mutations at residues 1 and 2 may
further improve solvent exposure of the peptide binding
pocket, impacting cation- interactions. Therefore, we pre-
pared four simultaneous mutations in CDYL to convert resi-
dues 1–4 to those of the CDY chromodomain
(P1S,P2Q,A3E,L4F, Fig. 1B). This mutant CDYL exhibited a
further 10-fold improvement in binding to the H3K9me3 pep-
tide (Fig. 4B, Table 3). As compared with CDY, this mutant
CDYL bound only 4-fold weaker to the H3K9me3 peptide, yet
the bindingwas 2-fold stronger than thatmeasured for CDYL2.
To test the affinity of these CDYLmutants for H3K9me3 in a
cell-based assay, we transiently expressed full-length CDYL
polypeptides bearing the A3E,L4F and P1S,P2Q,A3E,L4F
mutations in NIH3T3 cells. As Fig. 5 shows, both mutant pro-
teins were exclusively localized to the cell nucleus and were
excluded from the nucleoli as was the wild-type CDYL protein
(Fig. 3B). Interestingly, the nuclear distribution of the mutant
proteins in relation to the DAPI dense areas and regions of
pericentric heterochromatin with H3K9me3 varied among dif-
ferent cells. Three types of localization patterns for CDYL
mutants could be observed (Fig. 5C). In a substantial number of
cells, both mutants showed diffuse staining (type I) that was
excluded from pericentromeric heterochromatin and is remi-
niscent of the wild-type CDYL protein (Figs. 3B and 5). Inter-
estingly, in some cells the A3E,L4Fmutant CDYL showed some
overlap with DAPI dense regions and H3K9me3 modification
as indicated by the yellow areas in the merged images (type II).
Although the P1S,P2Q,A3E,L4F mutant CDYL exhibited both
type I and type II localization patterns, it also showed punctate
overlap with pericentromeric heterochromatin (type III), rem-
iniscent of the CDY protein (Fig. 3A). Overall, the gradual
changes in subnuclear localization observed support the bio-
chemical function of these point mutations.
Other Potential Binding Sites for CDY and CDYL2 in
Chromatin—In addition to H3K9me3, other lysine-methylated
ARK(S/T) motifs depicted in Fig. 6A may recruit CDY family
chromodomains. Therefore, we measured dissociation con-
stants for the binding ofCDY,CDYL2,wild-typeCDYL, and the
mutant CDYL chromodomains to four additional peptides (Fig.
6B, Tables 1 and 3).We found the binding of the CDY chromo-
domain toH3K27me3 andH3tK27me3 peptides to be 150- and
15-fold weaker, respectively, than binding to the H3K9me3
peptide. Interaction of CDY chromodomain with the
H1.4K26me3 peptide was also found to be 20-fold weaker than
binding to the H3K9me3 peptide. Surprisingly, the CDY chro-
modomain bound to the G9a-K185me3 peptide with dissocia-
tion constant similar to that found for the H3K9me3 peptide
(Fig. 6B). When we compared binding differences among
monomethylated peptides, we found the dissociation constant
for binding of CDY to H3K9me1 and G9a-K185me1 peptides
are significantly different, 3.4 and 36 M, respectively.
Together, these results suggest the CDY chromodomain is
capable of discriminating between various lysine-methylated
ARK(S/T) motifs.
Interestingly, the CDYL2 and the mutant CDYL chromodo-
mains are substantially less selective than the CDY chromodo-
main in binding to different ARK(S/T) motifs (Fig. 6B). Among
the peptides tested, theH3K27me3peptide showed theweakest
TABLE 3
Dissociation constants (M) measured by fluorescence polarization for recombinant mutant CDYL chromodomains interacting with synthetic
peptides as described under “Experimental Procedures”
Peptide Wild type A3E L4F A3E,L4F P1S,P2Q,A3E,L4F
H3 Lys-9
Unmodified 500 500 500 500 500
H3K4me3 500 500 500 500 500
H3K9ac 500 500 500 500 500
H3K9me1 500 240 60 500 55 10 13 2
H3K9me2 500 186 24 500 33 8 3.4 0.5
H3K9me3 500 216 31 452 81 25 11 2.2 0.3
H3K4me2K9me2 500 177 33 500 41 7 3.5 0.4
H3K9me3S10ph 500 500 500 500 500
H3 Lys-27
Unmodified 500 500 500 500 500
H3K27ac 500 500 500 500 500
H3K27me3 500 323 41 500 101 17 23 5
Testis H3 Lys-27
H3TK27me3 500 225 22 500 38 8 13 3
H1.4 Lys-26
Unmodified 500 500 500 500 100 24
H1.4K26me3 500 500 71 500 81 12 6.5 1.9
G9a Lys-185
Unmodified 500 500 500 500 500
G9aK185me3 500 182 31 500 37 7 40 10
G9aK185me1 500 271 53 500 52 19 19 3
Methyllysine Recognition by CDY Family of Chromodomains
19632 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 28•JULY 11, 2008
 at M
ax Planck Inst.Biophysikalische Chem
ie,O
tto Hahn Bibl,Pf.2841,37018 G
oettingen on M









interaction for all CDY family chromodomains. Although the
CDYL2 chromodomain exhibits similar binding to G9a-
K185me3, H1.4K26me3, H3tK27me3, and H3K9me3 peptides,
the mutant CDYL chromodomain is able to discriminate and
bind strongly to the H3K9me3 peptide. The variability in disso-
ciation constants listed inTables 1 and 3 underscores the role of
sequence differences in CDY family chromodomains for the
specificity of their interactions with modified histone tails.
DISCUSSION
The expansion of HP1-like chromodomains in diverse pro-
teins of higher eukaryotes suggests an increase in complexity of
epigenetic regulatory pathways from lower to higher
eukaryotes. The human genome contains the largest number of
HP1-like chromodomains that are encoded by 16 different
genes, and these encode proteins belonging to 5 different fam-
ilies, HP1, Suv91, Polycomb, CDY, and MPP8 (supplemental
Fig. S3). Among these factors, HP1 and Suv91 are typically
found associated with H3K9me3 regions of chromatin. The
CDY and MPP8 families appear to be hallmarks of vertebrate
genomes. The origin of their expansion intomultiple variants is
not well known. Previously, an evolutionary tree was delineated
for the human CDY family genes, which suggested CDYL is the
ancestor of CDY and CDYL2 (6). This would suggest that evo-
lutionary forces first abolishedmethyllysine binding in anHP1-
like chromodomain to formulate CDYL; subsequently methyl-
lysine binding was gained in CDYL2 and CDY. This order of
events is unlikely because the genomes of simple vertebrates
like sea urchin or chicken encode only one CDY family gene
whose sequence suggests full capability of binding to lysine-
methylated ARK(S/T) motifs (Fig. 1B). Therefore, we assume
CDYL2 is the ancestor of CDY and CDYL proteins.
The CDYL chromodomain is unable to bind to any lysine-
methylated ARK(S/T) motif. We identified mutations in the
CDYL chromodomain that can impact the interaction of the
full-length protein with H3K9me3 regions of chromatin, sug-
gesting its chromodomain is significant for cellular localization.
Previous studies have implicated CDYL in transcriptional co-
repressor complexes containing multiple chromatin modifica-
tion enzymes and docking factors (39). Interestingly, the CDYL
protein co-purified with the methylated G9a protein in human
cell extracts (30). Together these results suggest the combined
action of another factor could make up for the missing portion
of the CDYL binding pocket. This may be related to a study on
the yeast histone deacetylase complex Rpd3S, where the com-
bined action of a PHD finger and a chromodomain from two
different polypeptides has been suggested to regulate binding to
H3K36me3 modification (40).
Although human CDY and CDYL2 chromodomains are able
to recognize a variety of lysine-methylated ARK(S/T) motifs,
there are substantial differences in their binding specificities.
We found that the CDY chromodomain preferentially binds to
the H3K9me3 peptide, whereas CDYL2 can equally interact
FIGURE 5. CDYLmutant chromodomain H3K9me3 interaction is sufficient for localization to pericentromeric heterochromatin. FLAG-tagged human
CDYL chromodomain mutants A3E,L4F (A), and P1S,P2Q,A3E,L4F (B) were transiently expressed in NIH3T3 cells. Cells were immunostained and analyzed as
described in Fig. 3. Cells ofmediumexpression level representative for three different types (I-III) of nuclear distribution found for bothmutants are shown. The
scale bar is 10m. C, the occurrence of type I, II, or III nuclear distribution in each cell for wild-type CDYL (WT), CDYL A3E,L4F, and CDYL P1S,P2Q,A3E,L4F were
statistically analyzed. Frequency plots resulting from the evaluation of at least 40 cells each from different transfection experiments are shown.
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with H3K9me3, H3tK27me3, andH1.4K26me3 peptides. Stud-
ies on mouse polycomb (Pc) variants also showed substantial
diversity in binding selectivity toward H3K9me3 and
H3K27me3 (21). For example, Pc1 (Cbx2) showed equal bind-
ing toH3K9me3 andH3K27me3, whereas Pc2 (Cbx4) showed a
3-fold stronger binding to H3K9me3 (21). The mammalian Pc
proteins are believed to contribute to chromatin architecture
on the inactive X chromosome and reflect assembly of faculta-
tive heterochromatin using H3K9me3 and H3K27me3 modifi-
cations (21). The same chromatin modifications also seem to
contribute to chromatin regulation during spermatogenesis
(41, 42). Additional studies are required to determine how var-
iability inmethyllysine recognition byCDY,CDYL, andCDYL2
could impact on their functions in chromatin regulation in tes-
tis. Acetylation of histone H4 during spermatogenesis is sug-
gested to hinge on the expression of CDY and CDYL, and these
polypeptides are unique for their ability to link a repressive
modification like H3K9me3 with that of histone H4 acetylation
(8). Enrichment of CDY variants in testis might contribute to
genomic imprinting, which leads to appropriate transcription
of paternally derived genes (for review, see Refs. 31, 32, and 43).
Unfortunately, at present only limited knowledge is available on
the features of chromatin in human male germ cells.
Recently, we reported substantial evolutionary differences in
the binding abilities of CHD double chromodomains that cor-
relatewith limited amino acid changes (44). These observations
are consistent with complex control mechanisms associated
with signaling enzymatic function in higher eukaryotes (45). In
FIGURE 6. Interaction of CDY family chromodomainswithmethyllysines embedded in ARK(S/T)motifs. A, the ARK(S/T)motifs in chromatin that are
potential binding sites of CDY family chromodomains are specified. The various methyltransferases that are known to establish the different methyla-
tions are listed above each lysine residue. B, fluorescence polarization binding assays were used to determine the specificities of the CDY, CDYL2, and
CDYL P1S,P2Q,A3E,L4F chromodomains to each of these peptides containing a trimethyllysine. Averages from at least three independent measure-
ments are plotted.
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both the CDY and CHD families of chromodomains, catalytic
activity is physically separable from an N-terminal chromodo-
main that appears to link input or output signals associated
with epigenetic regulation. Another role of the chromodomain
may be direct participation in enzymatic activity. For example,
studies on Suv91 (supplemental Fig. S3) showed deletion of
the chromodomain or point mutations in the aromatic cage
impaired enzyme activity (i.e. trimethylation of H3K9) despite
the presence of an intact catalytic SET domain (46). Additional
studies are necessary to further dissect the catalytic function of
CDY family ECH domains and subsequently investigate
whether their chromodomains directly participate in enzy-
matic activity and/or serve to link with input/output signaling
networks.
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